MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$110,734K
Inventories
$8,066K
Trade and other
receivables, net
$6,867K
Prepaid expenses and
other current assets
$4,516K
Total current assets
$130,183K
Right-of-use assets, net
$4,468K
Property and equipment,
net
$3,839K
Other non-current
assets
$2,635K
Total assets
$141,125K
Accumulated deficit
-$455,055K
Total liabilities and
stockholders deficit
$141,125K
Total stockholders
deficit
-$34,054K
Additional paid-in capital
$420,877K
Common stock, 0.001 par
value. authorized...
$124K
Total liabilities
$175,179K
Liability related to the
sale of future...
$62,083K
Total current
liabilities
$31,753K
Royalty obligations,
net
$26,914K
Notes payable, net
$25,099K
Deferred revenue, net of
current portion
$19,118K
Other non-current
liabilities
$6,053K
Lease liabilities
$4,159K
Loans payable,
current
$13,661K
Accounts payable
$11,889K
Accrued expenses
$3,449K
Deferred revenue,
current
$1,092K
Liability related to the
sale of future...
$1,000K
Lease liabilities,
current
$662K
Back
Back
Balance Sheet
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)
source: myfinsight.com